您现在的位置: 首页> 研究主题> X刀

X刀

X刀的相关文献在1985年到2023年内共计96448篇,主要集中在肿瘤学、特种医学、神经病学与精神病学 等领域,其中期刊论文437篇、会议论文7篇、专利文献96004篇;相关期刊176种,包括泰山卫生、中国医疗设备、现代诊断与治疗等; 相关会议7种,包括2007'中国数字医学论坛、第五届全国肿瘤放疗及综合治疗会议、第二届全国肿瘤靶向治疗技术大会暨首届立体定向放射治疗技术学术研讨会等;X刀的相关文献由50000位作者贡献,包括不公告发明人、王磊、王伟等。

X刀—发文量

期刊论文>

论文:437 占比:0.45%

会议论文>

论文:7 占比:0.01%

专利文献>

论文:96004 占比:99.54%

总计:96448篇

X刀—发文趋势图

X刀

-研究学者

  • 不公告发明人
  • 王磊
  • 王伟
  • 李伟
  • 陈亮
  • 张伟
  • 程永亮
  • 刘飞香
  • 王强
  • 夏毅敏
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

作者

    • 薛斌跃
    • 摘要: 1967年,第一代伽玛刀(γ刀)问世;1975年,第二代伽玛刀出现;1984年,第三代伽玛刀在医疗领域中投入应用;1992年,世界上第一个X刀治疗中心成立。在2020年的今天,X刀、伽玛刀已经发展成为立体定向放射治疗的重要手段。X刀与伽玛刀X刀,又称为立体定向放射外科系统。X刀由直线加速器、头颅支撑固定器以及计算机工作站等部分组成。X刀治疗可以精确摧毁靶区内的病变组织(射束准确度可达0.2mm),同时又不会伤害靶区外的组织,并且可以避免传统手术治疗带来的术后出血、术后感染等风险。
    • 狄杰; 王强; 亓飞
    • 摘要: Objective:To analyze the clinical efficacy of conventional TACE combined with stereotactic body X knife treatment on liver cancer.Methods:Retrospectively analyze data of 96 primary liver cancer patients who were randomly divided into three groups,X -knife group,TACE group,X -knife combined with TACE group,32 cases in each.Observation indicators mainly include objective effect,AFP,ALT,AST,kidney (BUN,Cr),side effects,and sur-vival.Results:General date of three groups of patients,including gender,HBSAg (+),and the Child -pugh score (A /B)were compared,the difference had no statistical significance (P >0.05).After 4 week's treatment,curative effects were compared among three groups.The difference between X - knife group and conventional TACE alone group was not statistically significant (incidences of efficiency:28.13% vs 21.88%,P >0.05).Joint group had bet-ter curative effects than conventional TACE group,with statistical differences between two groups(incidences of effi-ciency:46.88% vs 21.88%,P 0.05)among the liver and kidney function of three groups after the treatment.Conclusion:Combined with conventional X -knife treatment of primary liver cancer treatment has obvious curative effect,more effective than conventional TACE group.Combined with conventional X -knife treatment for primary liver cancer than conventional treatment group and X -knife can improve the patient's quality of life,prolong patient survival.%目的:探讨经肝动脉化疗栓塞(TACE)结合立体定向体部 X -刀治疗肝癌的临床疗效。方法:回顾性分析我院2012年3月-2013年11月治疗的原发性肝癌患者96例的临床资料,随机分成三组,X -刀组、TACE 组以及联合组(X -刀联合 TACE)各32例。观察指标主要包括:客观疗效、甲胎球蛋白(AFP)、肝脏功能(ALT,AST)、肾脏功能(BUN,Cr)、毒副反应、生存时间。结果:所选择的各分类病人的一般资料对比情况,包括性别、乙肝表面抗原状况及 Child -pugh 评分(A /B)等方面,其差异不具有统计学意义(P >0.05),具有可比性。近期疗效情况:治疗结束1月后,与单纯的 TACE 组相对比,单纯 X -刀治疗组病人总体有效率差异无统计学意义(有效率:28.13% vs 21.88%,P =0.564);与单纯 TACE 治疗组比较,联合治疗组病人总的有效率显著升高,差异具有统计学意义(有效率:46.88% vs 21.88%,P =0.035)。生存时间:联合组、单纯 X -刀组、单纯 TACE 组三组的生存时间分别为(13.2±2.6)个月、(8.8±2.2)个月、(5.8±2.1)个月。联合组与单纯 TACE 组及单纯 X -刀组比较,生存时间有所延长,差异具有统计学意义。治疗结束1月后与单纯 TACE组比较,联合治疗组病人卡氏评分高,差异具有统计学意义(t =2.18,P =0.0331)。三组治疗后肝、肾脏功能均较本组病人治疗前改善,差异具有统计学意义(P <0.05);三组病人治疗后肝肾功能组间相比较无统计学意义(P >0.05)。结论:TACE 与 X -刀治疗相结合的方法治疗原发性肝癌在临床上有着显著的疗效,较单纯TACE 治疗组能起到更为有效的抑制和杀伤肿瘤的作用。TACE 与 X -刀治疗方法相结合无疑较单纯 TACE治疗组和单纯 X -刀治疗组能更好的改善患者的近期生存质量,并且能在一定程度上延长患者的生存时间,不失为是一种风险低、临床有效率高、并发症并不增多的有效治疗方案之一。TACE 与 X -刀治疗相结合的治疗方案治疗原发性肝癌较单纯 TACE 治疗组和单纯 X -刀治疗组对胃肠道功能以及肾脏机能损害减小,并且患者能够耐受,并发症风险低。
    • 尹立杰; 丁田贵; 彭兆祥; 顾广海
    • 摘要: 目的 比较分析3D-CRT、X刀和OUR-QGD型体部γ刀(简称γ刀)技术在局部晚期胰头癌治疗计划的剂量学数据,为临床选择放疗技术提供参考.方法 30例局部晚期胰头癌患者,每例设计3D-CRT、X刀和γ刀三种治疗计划.X刀和γ刀处方剂量设定400 cGy/次,3D-CRT处方剂量200 cGy/次,包绕90%PTV.根据LQ模型进行生物等效剂量换算.比较三种计划的PTV靶区适形指数和均匀性指数,通过DVH图计算靶区剂量和周围危机器官剂量.结果 靶区剂量:γ刀最高,X刀计划次之,3D-CRT计划最低.靶区适形度和均匀性指数:3D-CRT计划最好,X刀计划次之,γ刀计划最差.危机器官剂量:γ刀最低,X刀计划次之,3D-CRT计划最高.结论 根据物理剂量学数据,γ刀技术可显著提高靶区剂量,更好保护周围正常组织.3D-CRT技术靶区适形度最好、剂量均匀性最好,但正常组织剂量较大,X刀技术介于两者之间.
    • 郭化东; 常金; 张艳英; 李爱菊; 张本华
    • 摘要: Objective:To study trigeminal neuralgia treated by X - ray knife using low dose and big diameter collima-tor. Methods:To treat 95 cases who have primary trigeminal neuralgia using X - ray knife ,10 ~ 13mm diameter collimator, 17Gy extend to 29Gy doses in the center by single irradiation. to select target using the trigeminal impression on the crista of petrosal bone. Results:Pain belief had disappeared for 37cases ,diminished significantly for 26 cases and effectively for 18cases in 1 ~ 5 monthes,14case were not effective. 5 cases aggravated in 1 month,2 cases had recurred after 8,10monthes respectively and been treated again whose pains disappeared;all cases had no complications. Conclusions:The trigeminal impression on the crista of petrosal bone is a dependable symbol for the treatment. 17GY is a effective dose for the treatment in large collimator and 29Gy is better.%目的:对原发性三叉神经痛作 X -刀大口径准直器及低剂量放射治疗的临床研究。方法应用 X -刀照射治疗原发性三叉神经痛患者95例,利用岩骨嵴三叉神经节压迹这一骨性标志选择靶点,10~13 mm 口径准直器,中心剂量17 Gy 推量至29 Gy,单次照射。结果在1~5个月缓解或消失,随着放疗剂量的加大,起效时间缩短,疼痛缓解效果较好;治愈37例,明显改善26例,有效18例,无效14例。5例病人在1个月内疼痛症状加重现象,2例分别于8,10个月后疼痛复发,经再次治疗后疼痛症状消失;全部病例均无并发症。结论岩骨嵴三叉神经节压迹这一骨性标志是原发性三叉神经痛放疗的可靠标志点,17Gy 是大口径准直器 X -刀治疗原发性三叉神经痛有效的剂量,29Gy 的治疗效果更好。
    • 赵进沛; 张富利; 王雅棣; 孔雪梅; 闫妍
    • 摘要: 目的:建立外置立体定向治疗系统医用加速器性能与防护检测方法.方法:参照GBZ 126-2011、GB/T 19046--2003以及自有的检测设备,对医用加速器相关性能和防护指标进行检测;用交叉刻度的方法,采用待测的医用加速器辐射源,以在计量部门检定后的0.65 cm3电离室测量系统作为量值传递媒介,对针尖式电离室进行刻度,从而实现对立体定向放射治疗计划剂量与实测剂量的偏差指标的检测.结果:所采用的方法可以实现相关指标的检测,检测结果符合有关标准要求.结论:该研究所采用的外置立体定向治疗系统医用加速器性能与防护检测方法,可以作为对此类装备进行状态或稳定性检测的参考.
    • 欧阳斌; 王振宇; 碧秀
    • 摘要: γ knife and Linac radiosurgery are the most widely used stereotactic radiosurgery (SRS) modalities with similar accuracy and dose conformality, Linac radiosurgery is better in dose heterogeneity and more efficient for com-plex target. There is no significant difference between the two techniques in terms of disease control rate and complica-tions in acoustic neuroma, meningioma, brain metastases, arteriovenous malformations, pituitary adenomas and trigemi-nal neuralgia. γ knife is widely used with diverse clinical experience, whereas linac radiosurgery with more diverse treatment patterns and wider scope.%γ刀和X刀是应用最广泛的两种立体定向放射外科技术,两者的治疗精度相同,剂量分布的适形性一致、均匀性X刀优于γ刀,对于复杂靶区X刀治疗效率更高。通过分析比较两种技术在听神经瘤、脑膜瘤、脑转移瘤、脑动静脉畸形、垂体腺瘤和三叉神经痛等病变中的治疗效果,表明两种技术在病变控制率、正常组织损伤率等方面无差别;γ刀治疗的临床应用经验更丰富,X刀的治疗方式则更多样化,适用范围更广。
    • 孙红; 孟庆勇; 陈小妹; 陈先平; 董东
    • 摘要: 目的 评价X线立体定向放射外科治疗术后残留垂体腺瘤在控制肿瘤生长和改善内分泌方面的长期疗效.方法 回顾性分析1998年3月至2008年3月X刀治疗的有完整随访结果共206例术后残留垂体腺瘤资料.病灶直径5~35 mm,平均为16.4 mm.治疗时无功能性垂体腺瘤平均中心剂量为22 Gy(20~25 Gy),周边剂量为10 Gy(8~12 Gy);功能性腺瘤平均中心剂量为28Gy(25~30 Gy),周边剂量为12 Gy(10~14 Gy),覆盖病灶体积80%以上.结果 随访24个月以上,肿瘤缩小(含消失)129例(62.6%),无变化74例(35.9%),增大3例(0.15%);在功能性腺瘤中,内分泌恢复正常72例(56.5%),下降53例(42.0%),升高2例(1.5%).所随访的患者无死亡,无严重并发症,无垂体功能低下,35例视力障碍的患者中有13例视力明显好转.结论 X刀治疗术后残留垂体腺瘤临床疗效肯定,是治疗术后残留垂体腺瘤的重要手段.%Objective To evaluate the long tram effect of X - knife stereotactic radio surgery on the tumor growth control and improvement of incretion of the residual pituitary adenomas after operation. Methods From March 1998 to March 2008, 206 patients were treated with X - knife stereotactic radio surgery for residual pituitary adenomas. The lesion diameters ranged from 5mm to 35 mm with a mean diameter of 16.4 mm. For the nonfunctional adenoma, the mean center dose was 22 Gy (20-25 Gy ), and marginal dose 10 Gy (8~12 Gy); for the functional adenoma, the mean center dose was 28 Gy(25~30 Gy), and marginal dose 12 Gy( 10~14 Gy); over 80% lesion volume was covered. Results All patients had been followed - up for over 24 months. The tumor size decreased or completely disappeared in 129 eases ( 62. 6% ), no change was found in 74 cases ( 35. 9% ), evidence of progression was shown in 3 cases ( 0.15% ). For the functional adenoma ones, the incretion was renewed in 72 cases ( 56. 5% ), decreased in 53 cases ( 42.0% ), and increased only in 2 cases ( 1.5% ). There was no death, no serious complication and no hypopituitarism; moreover, 13 of the total 35 patients with visual disorder got obvious improvement of sight. Conclusion X - knife stereotactic radiosurgery is an effective method in the treatment of residual pituitary adenomas.
    • 徐培坤; 赵亮; 孟庆勇
    • 摘要: Objective To study the differences in efficacy and complications between single and fractionated therapy by X-knife for pituitary adenomas. Methods Clinical data of 121 patients with pituitary adenomas treated by X-knife were analyzed retrospectively, and divided into single therapy group (n = 70) and fractionated therapy group (n = 51) according to the treatment methods. The differences in efficacy and complication rates between two groups were compared. Results Overall tumor control rate was 95.9% after treatment, including 67 patients (95.7%) in single therapy group and 49 (96.1%) in fractionated therapy group. The control rate of hormone level after treatment was 38.0%, including 28 patients (40.0%) in single therapy group and 18 (35.3%) in fractionated therapy group. There were no statistically significant differences in control rates of tumor and hormone level between the two groups (P > 0.05), while there was a statistically significant difference in the complication incidence of grades 1, 2, 3 between the two groups (P < 0.05). Conclusion Fractionated therapy with proper treatment intervals is a reliable method for reducing the complications of pituitary adenomas.%目的 探讨垂体腺瘤行X-刀单次治疗与分次治疗后疗效与并发症的差异.方法 回顾性分析121例经X-刀治疗的垂体腺瘤病人的临床资料,根据治疗方式不同分为单次治疗组(70例)与分次治疗组(51例),比较两组疗效及并发症发生率的差异.结果 治疗后总体肿瘤控制率为95.9%,其中单次治疗组肿瘤控制67例(95.7%),分次治疗组肿瘤控制49例(96.1%);治疗后激素水平控制率为38.0%,其中单次治疗组激素水平控制28例(40.0%),分次治疗组激素水平控制18例(35.3%);两组肿瘤控制和激素水平控制差异均无统计学意义(P >0.05).而治疗后两组l、2、3级并发症发生率差异均有统计学意义(P<0.05).结论 适当的治疗间隔时间的分次治疗是降低并发症的可靠方法.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号